Ben Dijkmans

Author PubWeight™ 15.55^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).	Arthritis Rheum	2005	4.12
2	Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis.	Arthritis Rheum	2006	3.26
3	Consensus on a core set of domains for psoriatic arthritis.	J Rheumatol	2007	1.60
4	Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidity.	Arthritis Rheum	2004	1.42
5	Predicting the outcome of ankylosing spondylitis therapy.	Ann Rheum Dis	2011	1.35
6	Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period.	Arthritis Rheum	2008	1.27
7	Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis.	J Rheumatol	2003	1.23
8	pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease.	J Rheumatol	2010	0.92
9	A non-inferiority trial of an attenuated combination strategy ('COBRA-light') compared to the original COBRA strategy: clinical results after 26 weeks.	Ann Rheum Dis	2013	0.92
10	Dutch patients with familial and sporadic ankylosing spondylitis do not differ in disease phenotype.	J Rheumatol	2002	0.86